Real-world prophylactic usage of recombinant factor IX Fc in Sweden: A report from the Swedish National Registry for bleeding disorders

Affiliations

• ¹ Department of Medicine, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
• ² Sahlgrenska Academy, Institution for Nursing Science and Health at Gothenburg University, Gothenburg, Sweden.
• ³ Department of Hematology, Coagulation Unit, Karolinska University Hospital, Stockholm, Sweden.
• ⁴ Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
• ⁵ Department of Acute Internal Medicine and Geriatrics, Linköping University, Linköping, Sweden.
• ⁶ Pediatric Coagulation Unit, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
• ⁷ MMK and CLINTEC, Karolinska Institutet, Stockholm, Sweden.
• ⁸ Department of Translational Medicine and Department of Hematology, Oncology and Radiation Physics, Lund University, Skåne University Hospital, Malmö, Sweden.
• ⁹ Department for Paediatric Haematology and Oncology, Children's Hospital, Skåne University Hospital, Malmö, Sweden.
• ¹⁰ Department of Clinical Sciences, Paediatrics, Lund University, Malmö, Sweden.
• ¹¹ Swedish Orphan Biovitrum AB, Stockholm, Sweden.